TP53 and neoplasm: Consistent with the tumour growth curve, the reduction of tumour weight by PHLDB3 depletion as compared with respective control was more profound in HCT116p53+/+ groups (65.9% reduction) than that in HCT116 p53−/− groups (22.8% reduction) (Fig. 8d).